Cullinan Therapeutics (CGEM) Tax Rate (2022 - 2023)

Cullinan Therapeutics' (CGEM) quarterly Tax Rate came in at 35.53% in Q4 2023, down 4209.0% year-on-year from 0.86% in Q4 2022, and down 641.29% quarter-over-quarter from 6.56% in Q4 2022.

Cullinan Therapeutics (CGEM) Tax Rate (2022 - 2023) Analysis & Trends

Cullinan Therapeutics' Tax Rate history runs 2 years deep, the most recent figure standing at 35.53% for Q4 2023.

  • On a quarterly basis, Tax Rate fell 4209.0% year-over-year to 35.53% in Q4 2023; TTM through Dec 2023 was 8.33%, a 3614.0% decrease from a year earlier, with the FY2024 full-year figure at 21.09%, up 2942.0% from the prior year.
  • Tax Rate declined to 35.53% in Q4 2023 per CGEM's latest filing, from 6.56% in the prior quarter.
  • Across five years, Tax Rate topped out at 60.28% in Q1 2022 and bottomed at 35.53% in Q4 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -0.34%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 12.29%
4 NuCana 279.75 Bn 279.75 Bn - -5.41%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 17.68%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 12.51%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 33.09%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Cullinan Therapeutics 368.65 Mn 368.65 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -35.53%
Dec 31, 2023 -35.53%
Dec 31, 2023 -35.53%
Dec 31, 2022 6.56%
Dec 31, 2022 6.56%
Dec 31, 2022 6.56%
Sep 30, 2022 9.20%
Sep 30, 2022 9.20%
Sep 30, 2022 9.20%
Jun 30, 2022 27.51%
Jun 30, 2022 27.51%
Jun 30, 2022 27.51%
Mar 31, 2022 60.28%
Mar 31, 2022 60.28%
Mar 31, 2022 60.28%